Bio-Matrix Scientific Group Inc Company Profile, Contacts & Intelligence

Bio-Matrix Scientific Group Inc Overview

Bio-Matrix Scientific Group, Inc., through its subsidiary, Regen BioPharma, Inc., is engaged in the development of regenerative medical applications. The Company focuses on licensing from other entities up to the point of successful completion of Phase I and or Phase II clinical trials, after which it intends to sell or license those developed applications or advance the application further to Phase III clinical trials. Its products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax and Small Molecules. The Company is focused on the development of HemaXellerate I, a cellular therapy designed to heal damaged bone marrow. HemaXellerate II is intended to be a universal donor endothelial cell-based therapeutic. dCellVax is intended to be a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is intended to be an autologous cellular product. The Company identifies small molecules via a high throughput screening program.

Headquarters

La Mesa, California

Website

regenbiopharma.com

Industry

Pharmaceutical Manufacturing

Founded

1998

NAICS

Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

Bio-Matrix Scientific Group Inc Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Bio-Matrix Scientific Group Inc People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Bio-Matrix Scientific Group Inc

Explore companies in related markets and compare their industry and employee estimates.